[1] ZHAO D,LIU J,WANG W,et al.Epidemiological transition of stroke in China:Twenty-one-year observational study from the sino-monica-beijing project[J].Stroke,2008,39(6):1668.
[2] 傅毅,刘建荣,陈生弟.同型半胱氨酸与脑血管病[J].临床神经病学杂志,2003,16(6):189.
[3] 宋笑凯,李淮玉.同型半胱氨酸与心脑血管疾病风险的研究进展[J].医学综述,2011,17(4):522.
[4] 刘聪,童晓欣.血清同型半胱氨酸水平与青年缺血性脑卒中的关系[J].卒中与神经疾病,2010,17(3):167.
[5] The Homocysteine Studies Collaboration.Homocysteine and risk of ischemic heart disease and stroke:A meta-analysis[J].JAMA,2002,288(16):2015.
[6] CASAS JP,BAUTISTA LE,SMEETH L,et al.Homocysteine and stroke:Evidence on a causal link from mendelian randomisation[J].Lancet,2005,365(9455):224.
[7] XU X,LI J,SHENG W,et al.Meta-analysis of genetic studies from journals published in china of ischemic stroke in the han chinese population[J].Cerebrovasc Dis,2008,26(1):48.
[8] Hankey GJ,Eikelboom JW.Homocysteine and vascular disease[J].Lancet,1999,354(9176):407.
[9] 王杨,蒋善群,秦献辉,等.亚甲基四氢叶酸还原酶基因型对叶酸降同型半胱氨酸的影响[J].中华高血压杂志,2011,19(2):143.
[10] 陈芳,吕海东.中青年缺血性脑血管病与MTHFR基因多态性及血浆同型半胱氨酸的相关性[J].中华临床神经病学杂志,2014,13(5):492.
[11] LENTZ SR.Homocysteine and vascular disfunction[J].Life Science.1997,61(13):1205.
[12] TSAI JC,PERRELLA MA,YOSHIZUMI M,et al.Promotion of vascular smooth muscle cell growth by homocysteine:A link to atherosclerosis[J].Proc Natl Acad Sci USA,1994,91(14):6369.
[13] PEZZINI A,DEL ZOTTO E,PADOVANI A.Homocysteine and cerebral ischemia:Pathogenic and therapeutical implications[J].Curr Med Chem,2007,14(3):249.
[14] YANG Q,BOTTO LD,ERICKSON JD,et al.Improvement in stroke mortality in canada and the united states,1990 to 2002[J].Circulation,2006,113(10):1335.
[15] WANG X,QIN X,DEMIRTAS H,et al.Efficacy of folic acid supplementation in stroke prevention:A meta-analysis[J].Lancet,2007,369(9576):1876.
[16] SAPOSNIK G,RAY JG,SHERIDAN P,et al.Homocysteine-lowering therapy and stroke risk,severity,and disability:Additional findings from the hope 2 trial[J].Stroke,2009,40(4):1365.